News – Page 331 – Endpoints News

Biogen board replacement for Alex Denner, Susan Langer, is said to be the investor’s romantic partner

3 years ago

Alex Denner is out at Biogen as new CEO Viehbacher crafts a fresh board with Susan Langer, Caroline Dorsa

3 years ago

Telehealth marketer Ro pulls its Wegovy advertising amid ongoing supply shortages

3 years ago

Pending FDA's OK, Teva and Alvotech can bring their Stelara biosimilar to US market by 2025

3 years ago

FDA lays out what to expect at adcomm's selection of strains for Covid-19 vaccine campaign this fall

3 years ago

Charles River to work with Curigin on gene therapy treatment

3 years ago

VMLY&R Health spotlights 'craft' in pharma advertising with new global chief

3 years ago

Amgen and Horizon argue FTC's suit to block $28B merger is 'as misguided as it is unprecedented'

3 years ago

Once promising cancer therapy startup Oncorus admits defeat after laying off most of its staff

3 years ago

US Chamber of Commerce files second suit over Medicare's incoming drug price negotiations

3 years ago

Otsuka encourages Gen Z self-expression and 'living boldly' with mental health conditions

3 years ago

Catalent’s Q3 revenue fell 19% in delayed reveal of financial results

3 years ago

Xalud Therapeutics prioritizes gene therapies, with ALS now the focus and osteoarthritis on partner path

3 years ago

Scoop: InCarda terminates its PhIII trial for arrhythmia drug that was central to plans for an IPO

3 years ago

FDA sets action date for Phathom after trace carcinogens led to CRL, grants AstraZeneca priority review

3 years ago

Eccogene nabs $25M Series B for GLP-1 and a NASH drug candidate, as competitors lap the China biotech

3 years ago

Novo Nordisk ups investment in Denmark API manufacturing facility to $2.3B

3 years ago

Novartis adds $3.2B cash deal to M&A tally, snapping up Chinook and its late-stage kidney drugs

3 years ago

Rejuvenate Bio shrinks staff, pipeline focus as George Church spinout eyes 2024 gene therapy IND

3 years ago

Ex-Nightstar, Gyroscope and AGTC teams try again for next retinal gene therapy with $120M for Beacon Therapeutics

3 years ago

Intellia’s second CRISPR therapy reduces swelling attacks by 95% in hereditary angioedema

3 years ago

Exclusive: Illumina CEO Francis deSouza resigns, following challenge by activist investor

3 years ago

Adcomm votes yes on Leqembi full OK; Merck brings first IRA lawsuit; Special: LGBTQ+ leaders; Best-paying biopharma ...

3 years ago

FDA adcomm votes unanimously in favor of full approval for Eisai's new Alzheimer's drug

3 years ago

First page Previous page 328 329 330331332 333 334 Next page Last page